Skip to main content
Clinical Trials/NCT02862496
NCT02862496
Unknown
Not Applicable

Urine N-telopeptide, Serum Vit D, Parathormone and Calcium Levels in Hyperemesis Gravidarum

Kayseri Education and Research Hospital1 site in 1 country60 target enrollmentJune 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hyperemesis Gravidarum
Sponsor
Kayseri Education and Research Hospital
Enrollment
60
Locations
1
Primary Endpoint
Urine N- telopeptide levels in Pregnant Women with Hyperemesis Gravidarum
Last Updated
9 years ago

Overview

Brief Summary

The purpose of the study is to determine whether maternal bone resorption would be seen in Hyperemesis Gravidarum and could be detected in early period using serum vitamin D levels, serum calcium (Ca) levels, serum parathormone (PTH) levels and urine N- telopeptide levels in the patients with Hyperemesis Gravidarum.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
October 2016
Last Updated
9 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Kayseri Education and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Erdem Sahin

Principal Investigator

Kayseri Education and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • weeks of gestation pregnant women in both groups
  • İn hyperemesis group; 5% weight loss with regard to pre-gestation vomiting more than 3 times 3-5 % weight loss with ketonuria.

Exclusion Criteria

  • Other pathologies that cause nausea and vomiting in pregnancy gastroenteritis gastroparesis gall duct diseases hepatitis peptic ulcers appendicitis pyelonephritis ovarian torsion urinary tract stones diabetic ketoacidosis hyperthyroidism hyperparathyroidism migraine pseudo tumor cerebra vestibular diseases
  • Additionally some situations causing to rise of Ntx levels osteoporosis paget disease bone tumors
  • Furthermore some of conditions resulted in pre-menopausal osteoporosis or decreasing in Bone Mineral Density Malignancy Smoking Celiac Disease Depression Inflammatory Bowel Disease Pre-gestational Diabetes Chronic Kidney or Liver Disease Drug Use such as steroids, anticonvulsants, antiepileptic, heparin or low molecular weight heparin

Outcomes

Primary Outcomes

Urine N- telopeptide levels in Pregnant Women with Hyperemesis Gravidarum

Time Frame: 4 months

Serum Vitamin D Levels in Pregnant Women with Hyperemesis Gravidarum

Time Frame: 4 months

Serum Calcium Levels in Pregnant Women with Hyperemesis Gravidarum

Time Frame: 4 months

Serum Parathormone Levels in Pregnant Women with Hyperemesis Gravidarum

Time Frame: 4 months

Study Sites (1)

Loading locations...

Similar Trials